Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Evaluation of radiopharmaceuticals for the detection of acute myocardial infarction in man. [/sup 99m/Tc]

Journal Article · · Radiology; (United States)
OSTI ID:7345027
The accuracy of the scintigraphic diagnosis of acute myocardial infarction with /sup 99m/Tc-pyrophosphate, /sup 99m/Tc-tetracycline and /sup 99m/Tc-glucoheptonate was assessed in 63 patients, 43 of whom had clinical evidence of acute myocardial infarction. In 15, studies with both /sup 99m/Tc-tetracycline and /sup 99m/Tc-pyrophosphate were performed. Accuracy was greatest with /sup 99m/Tc-pyrophosphate (17/17 true positives, 8/10 true negatives) contrasted with /sup 99m/Tc-tetracycline (12/25 true positives, 6/11 true negatives) and /sup 99m/Tc-glucoheptonate (3/13 true positives, 2/2 true negatives). /sup 99m/Tc-pyrophosphate was the most sensitive tracer for the detection of acute myocardial infarction. The diagnostic accuracy with /sup 99m/Tc-glucoheptonate was poor.
Research Organization:
Harvard Medical School, Boston
OSTI ID:
7345027
Journal Information:
Radiology; (United States), Journal Name: Radiology; (United States) Vol. 121:2; ISSN RADLA
Country of Publication:
United States
Language:
English